| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/11/2006 | US20060100137 Monodispersed insulin polypeptide-oligomer conjugates; for administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 05/11/2006 | US20060099324 Composition comprising viscous fibers and viscosity-lowering proteins |
| 05/11/2006 | US20060099281 Herbal blood-pressure lowering and blood-lipid lower food |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099158 Preparation containing conjugated linoleic alcohol |
| 05/11/2006 | DE102004054054A1 Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines |
| 05/11/2006 | DE10055742B4 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/11/2006 | CA2762076A1 Aliphatic amine polymer salts for tableting |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2586021A1 Once a day formulation for phosphate binders |
| 05/11/2006 | CA2585925A1 Tetrahydro-pyridinyl pyrazole cannabinoid modulators |
| 05/11/2006 | CA2585555A1 Substituted phenylalkanoic acids |
| 05/11/2006 | CA2585550A1 Substituted carboxylic acids |
| 05/11/2006 | CA2584676A1 Polymorphs of sarsapogenin |
| 05/10/2006 | EP1655990A1 Wireless microphone communication system |
| 05/10/2006 | EP1655283A1 11beta-HSD1 Inhibitors |
| 05/10/2006 | EP1655037A1 Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 05/10/2006 | EP1654937A1 Composition comprising Momordica charantia and cinnamon |
| 05/10/2006 | EP1654269A1 Novel compounds |
| 05/10/2006 | EP1654263A1 Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654227A1 Bicyclic indoline sulfonamide derivatives |
| 05/10/2006 | EP1654225A2 Melanin concentrating hormone receptor antagonists |
| 05/10/2006 | EP1654224A1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 05/10/2006 | EP1653981A1 Fish protein hydrolyzate |
| 05/10/2006 | EP1653980A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 05/10/2006 | EP1653969A2 Pyrrolo 1,2-b pyridazine derivatives |
| 05/10/2006 | EP1653960A2 Melanin concentrating hormone receptor antagonist |
| 05/10/2006 | EP1653957A1 Piperidine compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1653945A2 Glycosidase inhibitors and methods of synthesizing same |
| 05/10/2006 | EP1653944A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | EP1653936A2 Solid dispersible and/or orodispersible non-filmy containing at least one type of active substance pharmaceutical composition and method for the preparation thereof |
| 05/10/2006 | EP1653934A2 Use of c-kit inhibitors for treating type ii diabetes |
| 05/10/2006 | EP1653911A2 Methods for treating metabolic syndrome |
| 05/10/2006 | EP1536799B1 Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic properties |
| 05/10/2006 | EP1450834B9 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1294874B1 Cd154 variants and uses thereof |
| 05/10/2006 | EP1265838B9 Novel fatty acid analogous |
| 05/10/2006 | EP1255764B1 Purine derivatives |
| 05/10/2006 | EP1214091B1 Therapies for chronic renal failure using one or more integrin antagonists |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | EP1137948B1 Methods and compositions to lower plasma cholesterol levels |
| 05/10/2006 | EP1104403B1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771263A Modified acacia and use thereof |
| 05/10/2006 | CN1771239A Vitamin d3 lactone derivatives |
| 05/10/2006 | CN1771233A Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome. |
| 05/10/2006 | CN1771232A 11-phenyl-dibenzodiazepine derivatives as RXR-antagonists |
| 05/10/2006 | CN1771040A Remedy for diabetes. |
| 05/10/2006 | CN1771038A Vitamin comprising pyroloquinoline quinone and use thereof |
| 05/10/2006 | CN1770986A Improved dietary fiber containing materials comprising low molecular weight glucan |
| 05/10/2006 | CN1769298A Fusion protein with antitumour action and its coding gene and uses |
| 05/10/2006 | CN1768851A Hyperlipemia treating medicine |
| 05/10/2006 | CN1768827A Diabetes treating medicine |
| 05/10/2006 | CN1768825A Method for preparing compound micron blood sugar-decreasing calcium-supplementing pseudostellaria root oral liquid |
| 05/10/2006 | CN1768824A Method for preparing compound blood sugar-decreasing calcium-supplementing powder, capsule and tablet with pseudostellaria root |
| 05/10/2006 | CN1768815A Weight-reducing Chinese medicinal formulation and preparation process thereof |
| 05/10/2006 | CN1768807A Chinese medicinal formulation for rehabilitating pancreatic islet function and decreasing blood sugar and preparation process thereof |
| 05/10/2006 | CN1768795A Hawthorn fruit physiological activity |
| 05/10/2006 | CN1768790A Medicine for treating diabetes and its complications and its preparing process |
| 05/10/2006 | CN1768759A Nkt cell-activating agents containing alpha-glycosylceramides |
| 05/10/2006 | CN1768757A Application of a kind of alpha glycosidase inhibitor in preparation of medicine to treat hyperlipemia of diabetes |
| 05/10/2006 | CN1768741A Instant release type orally administered medicinal composition |
| 05/10/2006 | CN1768735A Medicaments for diabetic complication and neuropathy, and uses thereof |
| 05/10/2006 | CN1768588A Cactus green tea(black tea) |
| 05/10/2006 | CN1255543C Expression and application of transduction peptides - human insulinogen fusion protein |
| 05/10/2006 | CN1255522C Aqueous extract of irid and usage |
| 05/10/2006 | CN1255406C Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
| 05/10/2006 | CN1255397C Lactone category compound of sweetsop as well as new usage in medicines and its preparing method |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255391C COLCHINOL derivatives as vascular damaging agents |
| 05/10/2006 | CN1255389C Morpholol with medicinal activity |
| 05/10/2006 | CN1255386C Substituted fused heterocyclic compounds |
| 05/10/2006 | CN1255382C Modulators of dopamine neurotransmission |
| 05/10/2006 | CN1255149C Medicinal composition |
| 05/10/2006 | CN1255144C Health care medicinal composition for regulating blood fat and its preparation |
| 05/10/2006 | CN1255116C Soft capsule of forest frog oil and its preparation method |
| 05/10/2006 | CN1255103C Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 05/10/2006 | CN1255050C Health care food and its making method |
| 05/09/2006 | US7041835 (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 05/09/2006 | US7041829 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041652 administering ascorbic acid, ascorbate or a derivative thereof in combination with quercetin-3-O-glucoside (isoquercetin), quercetin-4'-glucoside, quercetin-3'-glucoside, or quercetin-7-glucoside to increase bioavailability |
| 05/09/2006 | US7041651 Cellular uptake of bioactive agents |
| 05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041322 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 05/09/2006 | US7041319 Fenofibrate pharmaceutical composition having high bioavailabilty |
| 05/09/2006 | US7041314 GPE analogs and peptidominetics |
| 05/09/2006 | US7041305 Stable water in oil aminophylline emulsions |